• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对止血性丝氨酸蛋白酶抑制剂具有构象影响的因素:在血栓形成中的意义。

Factors with conformational effects on haemostatic serpins: implications in thrombosis.

作者信息

Hernández-Espinosa David, Ordóñez Adriana, Vicente Vicente, Corral Javier

机构信息

Department of Medicine, Centro Regional de Hemodonación, University of Murcia, Murcia, Spain.

出版信息

Thromb Haemost. 2007 Sep;98(3):557-63.

PMID:17849043
Abstract

Serpins are key actors of systems involving proteolytic reactions, such as the haemostatic system, as they are irreversible suicide inhibitors of serine proteases. The structural flexibility and physical properties of serpins that are required for their efficient inhibitory mechanism also make them especially vulnerable to even minor factors that induce conformational changes in the native form of these molecules, leading to a number of inactive conformations, such as latent, cleaved or polymers. Increasing numbers of conformational mutations affecting haemostatic serpins, mainly antithrombin, the main endogenous anticoagulant, have been described. These mutations cause circulating deficiencies of the molecules, in most cases due to intracellular retention, which may be associated with a hyper-coagulable state. Indeed, conformational mutations in antithrombin have been identified in patients with severe venous thrombosis, which has led to the hypothesis that these disorders might be included in the group of conformational diseases. Moreover, we have recently demonstrated that other factors, including both drugs, such as the treatment with L-asparaginase, or environmental factors, such as high temperatures or hyperlipidemia, may also have conformational consequences on hepatic antithrombin, thus resulting in intracellular aggregation and plasma deficiency, which may increase the risk of thrombosis. In this study, we review the causes of deficiency of haemostatic serpins that may be explained by conformational mechanisms, and their association with an increased risk of venous thrombosis.

摘要

丝氨酸蛋白酶抑制剂(Serpins)是涉及蛋白水解反应系统的关键参与者,如止血系统,因为它们是丝氨酸蛋白酶的不可逆自杀性抑制剂。丝氨酸蛋白酶抑制剂高效抑制机制所需的结构灵活性和物理特性,也使它们特别容易受到一些微小因素的影响,这些因素会导致这些分子天然形式的构象变化,从而产生许多无活性的构象,如潜伏型、裂解型或聚合物型。越来越多影响止血性丝氨酸蛋白酶抑制剂的构象突变被描述,主要是抗凝血酶,它是主要的内源性抗凝剂。这些突变导致分子在循环中的缺乏,在大多数情况下是由于细胞内滞留,这可能与高凝状态有关。事实上,在严重静脉血栓形成患者中已鉴定出抗凝血酶的构象突变,这导致了一种假说,即这些疾病可能属于构象性疾病。此外,我们最近证明,其他因素,包括药物,如用L-天冬酰胺酶治疗,或环境因素,如高温或高脂血症,也可能对肝脏抗凝血酶产生构象影响,从而导致细胞内聚集和血浆缺乏,这可能增加血栓形成的风险。在本研究中,我们回顾了可能由构象机制解释的止血性丝氨酸蛋白酶抑制剂缺乏的原因,以及它们与静脉血栓形成风险增加的关联。

相似文献

1
Factors with conformational effects on haemostatic serpins: implications in thrombosis.对止血性丝氨酸蛋白酶抑制剂具有构象影响的因素:在血栓形成中的意义。
Thromb Haemost. 2007 Sep;98(3):557-63.
2
Intracellular retention of hepatic serpins caused by severe hyperlipidemia.严重高脂血症导致肝脏丝氨酸蛋白酶抑制剂在细胞内潴留。
Liver Int. 2006 Aug;26(6):708-15. doi: 10.1111/j.1478-3231.2006.01274.x.
3
Detection of conformational transformation of antithrombin in blood with crossed immunoelectrophoresis: new application for a classical method.用交叉免疫电泳检测血液中抗凝血酶的构象转变:经典方法的新应用。
J Lab Clin Med. 2003 Nov;142(5):298-305. doi: 10.1016/S0022-2143(03)00136-7.
4
The conformational basis of thrombosis.血栓形成的构象基础。
Thromb Haemost. 2001 Jul;86(1):14-22.
5
Thrombosis as a conformational disease.血栓形成作为一种构象疾病。
Haematologica. 2005 Feb;90(2):238-46.
6
L-asparaginase-induced antithrombin type I deficiency: implications for conformational diseases.L-天冬酰胺酶诱导的I型抗凝血酶缺乏:对构象疾病的影响
Am J Pathol. 2006 Jul;169(1):142-53. doi: 10.2353/ajpath.2006.051238.
7
Inhibition of proteasome by bortezomib causes intracellular aggregation of hepatic serpins and increases the latent circulating form of antithrombin.硼替佐米对蛋白酶体的抑制作用会导致肝脏丝氨酸蛋白酶抑制剂在细胞内聚集,并增加抗凝血酶的潜在循环形式。
Lab Invest. 2008 Mar;88(3):306-17. doi: 10.1038/labinvest.3700717. Epub 2008 Jan 14.
8
Serpins: finely balanced conformational traps.丝氨酸蛋白酶抑制剂:精细平衡的构象陷阱。
IUBMB Life. 2002 Jul;54(1):1-7. doi: 10.1080/15216540213825.
9
High levels of latent antithrombin in plasma from patients with antithrombin deficiency.抗凝血酶缺乏症患者血浆中存在高水平的潜在抗凝血酶。
Thromb Haemost. 2017 May 3;117(5):880-888. doi: 10.1160/TH16-11-0866. Epub 2017 Feb 23.
10
Protein Z/Z-dependent protease inhibitor (PZ/ZPI) anticoagulant system and thrombosis.蛋白Z/依赖蛋白Z的蛋白酶抑制剂(PZ/ZPI)抗凝系统与血栓形成。
Br J Haematol. 2007 Apr;137(2):99-108. doi: 10.1111/j.1365-2141.2007.06548.x.

引用本文的文献

1
Analysis of AlphaFold and molecular dynamics structure predictions of mutations in serpins.丝氨酸蛋白酶抑制剂突变的 AlphaFold 和分子动力学结构预测分析。
PLoS One. 2024 Jul 5;19(7):e0304451. doi: 10.1371/journal.pone.0304451. eCollection 2024.
2
Treatment of Homozygous Type II Antithrombin Heparin-Binding Site Deficiency in Pregnancy.妊娠期纯合子II型抗凝血酶肝素结合位点缺乏症的治疗
Case Rep Obstet Gynecol. 2021 Sep 3;2021:4393821. doi: 10.1155/2021/4393821. eCollection 2021.
3
A small deletion in SERPINC1 causes type I antithrombin deficiency by promoting endoplasmic reticulum stress.
SERPINC1基因中的一个小缺失通过引发内质网应激导致I型抗凝血酶缺乏症。
Oncotarget. 2016 Nov 22;7(47):76882-76890. doi: 10.18632/oncotarget.12349.
4
Increased N-glycosylation efficiency by generation of an aromatic sequon on N135 of antithrombin.通过在抗凝血酶的N135位点产生芳香族糖基化序列来提高N-糖基化效率。
PLoS One. 2014 Dec 8;9(12):e114454. doi: 10.1371/journal.pone.0114454. eCollection 2014.